These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
89 related articles for article (PubMed ID: 15527221)
21. [Advances in research on capecitabine as adjuvant treatment for colon cancer after radical resection]. Zhang SZ Zhonghua Zhong Liu Za Zhi; 2010 Nov; 32(11):801-3. PubMed ID: 21223682 [No Abstract] [Full Text] [Related]
22. Capecitabine as adjuvant treatment for stage III colon cancer. Twelves C; Wong A; Nowacki MP; Abt M; Burris H; Carrato A; Cassidy J; Cervantes A; Fagerberg J; Georgoulias V; Husseini F; Jodrell D; Koralewski P; Kröning H; Maroun J; Marschner N; McKendrick J; Pawlicki M; Rosso R; Schüller J; Seitz JF; Stabuc B; Tujakowski J; Van Hazel G; Zaluski J; Scheithauer W N Engl J Med; 2005 Jun; 352(26):2696-704. PubMed ID: 15987918 [TBL] [Abstract][Full Text] [Related]
23. How the new oral antineoplastics affect nursing practice: capecitabine serves to illustrate. Szetela AB; Gibson DE Am J Nurs; 2007 Dec; 107(12):40-8; quiz 48-9. PubMed ID: 18049060 [TBL] [Abstract][Full Text] [Related]
24. Capecitabine dosing is not yet optimized for breast cancer. Hudis C; Traina T; Norton L Ann Oncol; 2010 Nov; 21(11):2291; author reply 2291-2. PubMed ID: 20501505 [No Abstract] [Full Text] [Related]
25. [Oral cytostatic drug in colorectal carcinoma. Selective tumor therapy at home]. MMW Fortschr Med; 2001 Mar; 143(13):51-2. PubMed ID: 11332023 [No Abstract] [Full Text] [Related]
27. Pharmacoeconomic analysis of capecitabine versus 5-fluorouracil/leucovorin as adjuvant therapy for stage III colon cancer in Taiwan. Hsu TC; Chen HH; Yang MC; Wang HM; Chuang JH; Jao SW; Chiang HC; Wen CY; Tseng JH; Chen LT Value Health; 2011; 14(5):647-51. PubMed ID: 21839401 [TBL] [Abstract][Full Text] [Related]
28. [Study of tolerability of capecitabine in postoperative adjuvant chemotherapy in colon cancer]. Matsuda C; Tamagawa H; Nishikawa K; Deguchi T; Kawata J; Iwase K; Takagi M; Fukui A; Nezu R; Tanaka Y Gan To Kagaku Ryoho; 2013 Mar; 40(3):327-30. PubMed ID: 23507593 [TBL] [Abstract][Full Text] [Related]
29. Dramatic response of recalcitrant warts as a side effect of colorectal cancer treatment with oral capecitabine. Bel B; Lorton MH; Darut-Jouve A; Vabres P Eur J Dermatol; 2011; 21(5):789-90. PubMed ID: 21700544 [No Abstract] [Full Text] [Related]
30. Capecitabine and sixth cranial nerve palsy. Dasgupta S; Adilieje C; Bhattacharya A; Smith B; Sheikh Mu J Cancer Res Ther; 2010; 6(1):80-1. PubMed ID: 20479552 [TBL] [Abstract][Full Text] [Related]
31. Comparison of protracted infusion 5-fluorouracil and capecitabine in adjuvant chemoradiotherapy for rectal cancer. Kurt M; Ozkan L; Kurt E; Cetintas SK; Aygun S; Ercan I; Yilmazlar T; Memik F Hepatogastroenterology; 2008; 55(85):1158-63. PubMed ID: 18795649 [TBL] [Abstract][Full Text] [Related]
32. Capecitabine: an overview of the side effects and their management. Saif MW; Katirtzoglou NA; Syrigos KN Anticancer Drugs; 2008 Jun; 19(5):447-64. PubMed ID: 18418212 [TBL] [Abstract][Full Text] [Related]
33. [Capecitabine-induced hyperpigmentation followed by hand-foot syndrome: a new case report]. Agharbi FZ; Meziane M; Benhemmne H; Daoudi K; Elmesbahi O; Mikou O; Mernissi FZ Ann Dermatol Venereol; 2012 Mar; 139(3):221-2. PubMed ID: 22401689 [No Abstract] [Full Text] [Related]
34. Inflammation of actinic keratoses and acral erythrodysesthesia during capecitabine treatment. Peramiquel L; Dalmau J; Puig L; Roé E; Fernández-Figueras MT; Alomar A J Am Acad Dermatol; 2006 Nov; 55(5 Suppl):S119-20. PubMed ID: 17052530 [No Abstract] [Full Text] [Related]
35. Re: Randomized trial of adjuvant therapy in colon carcinoma: 10-year results of NSABP protocol C-01. Alikhan MA; Phooskooru V; Kohli M J Natl Cancer Inst; 2004 Dec; 96(23):1794; author reply 1794. PubMed ID: 15572762 [No Abstract] [Full Text] [Related]
36. Efficacy and toxicity of capecitabine-based chemotherapy in patients with metastatic or advanced breast cancer: results from ten randomized trials. Wang Y; Yang H; Wei JF; Meng L Curr Med Res Opin; 2012 Dec; 28(12):1911-9. PubMed ID: 23145857 [TBL] [Abstract][Full Text] [Related]
37. [Coronary insufficiency after an oral intake of capecitabine]. Desramé J; Bronstein JA; Thiolet C; Bredin C; Ceccaldi B; Vergeau B; Farret O Gastroenterol Clin Biol; 2001; 25(8-9):829-30. PubMed ID: 11598548 [No Abstract] [Full Text] [Related]
38. Safety of capecitabine use in patients with liver dysfunction. Saif MW; Tejani MA Clin Adv Hematol Oncol; 2007 Sep; 5(9):730-2; discussion 736. PubMed ID: 17982413 [No Abstract] [Full Text] [Related]